It operates in the world of health and science. It has 14 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 73% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It met or beat analyst expectations in 6 of the last 6 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 18 buys and 5 sells. Management buying with its own money is usually read as a good sign.
A loss of $48.1M against $13K in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, ADXSD sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ADXSD is a small company that closed last year at a loss. The road back to profit runs through spending discipline.